Related Articles
Abnormal metabolic processes involved in the pathogenesis of non‑alcoholic fatty liver disease (Review)
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus
bZIP transmembrane transcription factor CREBH: Potential role in non‑alcoholic fatty liver disease (Review)
Ophiopogonin D ameliorates non‑alcoholic fatty liver disease in high‑fat diet‑induced obese mice by improving lipid metabolism, oxidative stress and inflammatory response
Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease